Compound (COMP) Buy Zone
Compound (COMP) Buy Zone
--------------------
BIAS
Mid-Term : Bullish
Long-Term : Bullish
Risk : High
Currently above our second trend-line support after a weak short term bounce, Compound is looking bullish in mid term. We expect at least a $260 retest on which the entire market depends.
--------------------
CCOMP/USDT LONG SETUP
Leverage : x3 - x5
Entry Price : 235 - 251
TP 1 : 259.5
TP 2 : 274
TP 3 : 289.5
TP 4 : 313
TP 5 : 331
TP 6 : 368
TP 7 : 407
TP 8 : 449+
Stop Loss : 209
*Maximum 2% of Portfolio.
*Unload 12.5% at each TP. Whenever TP 2 hits, Move stop loss to entry.
--------------------
--------------------
BIAS
Mid-Term : Bullish
Long-Term : Bullish
Risk : High
Currently above our second trend-line support after a weak short term bounce, Compound is looking bullish in mid term. We expect at least a $260 retest on which the entire market depends.
--------------------
CCOMP/USDT LONG SETUP
Leverage : x3 - x5
Entry Price : 235 - 251
TP 1 : 259.5
TP 2 : 274
TP 3 : 289.5
TP 4 : 313
TP 5 : 331
TP 6 : 368
TP 7 : 407
TP 8 : 449+
Stop Loss : 209
*Maximum 2% of Portfolio.
*Unload 12.5% at each TP. Whenever TP 2 hits, Move stop loss to entry.
--------------------
Trade active
CCOMP/USDT Entered entry zone
✨ Free Signals ✨
📈 Telegram : t.me/CRUNZEX
📉 Discord : discord.gg/jSKNPZsJVE
📊 Twitter : twitter.com/crunzex
📢 Automation trade FREE on Telegram!
📈 Telegram : t.me/CRUNZEX
📉 Discord : discord.gg/jSKNPZsJVE
📊 Twitter : twitter.com/crunzex
📢 Automation trade FREE on Telegram!
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
✨ Free Signals ✨
📈 Telegram : t.me/CRUNZEX
📉 Discord : discord.gg/jSKNPZsJVE
📊 Twitter : twitter.com/crunzex
📢 Automation trade FREE on Telegram!
📈 Telegram : t.me/CRUNZEX
📉 Discord : discord.gg/jSKNPZsJVE
📊 Twitter : twitter.com/crunzex
📢 Automation trade FREE on Telegram!
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.